HIV-1 Transcription Inhibition Using Small RNA-Binding Molecules is a research paper published in Pharmaceuticals (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Targeted Pharmaceuticals
Grant: GMU#223390
Targeted Pharmaceuticals
Grant: AI078859
Targeted Pharmaceuticals
Grant: AI074410
Targeted Pharmaceuticals
Grant: AI127351-01
Targeted Pharmaceuticals
Grant: AI043894
Targeted Pharmaceuticals
Grant: NS099029
Targeted Pharmaceuticals
Grant: DA050176
Targeted Pharmaceuticals
Grant: 12175081
Targeted Pharmaceuticals
Grant: CCNU22QN004
NIAID NIH HHS
Grant: R21 AI127351
NINDS NIH HHS
Grant: R01 NS099029
NIDA NIH HHS
Grant: R21 DA050176
NIAID NIH HHS
Grant: R21 AI078859
NIAID NIH HHS
Grant: R01 AI043894
NIAID NIH HHS
Grant: R21 AI074410
National Institutes of Health
Grant: 7R21AI078859-02
HIV-1 TAR derived miRNA: Implications for Latency and Pathogenesis
National Institutes of Health
Grant: 5R01AI043894-13
HIV-1 Inhibition Using Tat peptide derivatives
National Institutes of Health
Grant: 1R21AI127351-01
A radiation-induced cellular stress activates HIV and induces killing of infected cells
National Institutes of Health
Grant: 5R01NS099029-02
HIV neuropathogenesis related to exosomes containing HIV non-coding RNAs
National Institutes of Health
Grant: 1R21AI074410-01A1
Effect of chromatin remodelers/modifiers on HIV-1 Tat activated transcription
National Institutes of Health
Grant: 1R21DA050176-01
Effect on CBD on Exosome release from CNS infected cells
FWCI
0.99
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals